Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMorgan Sindall Group Regulatory News (MGNS)

Share Price Information for Morgan Sindall Group (MGNS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,460.00
Bid: 2,450.00
Ask: 2,460.00
Change: 5.00 (0.20%)
Spread: 10.00 (0.408%)
Open: 2,435.00
High: 2,460.00
Low: 2,425.00
Prev. Close: 2,455.00
MGNS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

7 Mar 2017 10:39

RNS Number : 7428Y
Morgan Sindall Group PLC
07 March 2017
 

MORGAN SINDALL GROUP plc

(the "Company")

 

Notification of Transactions by Directors

 

The Morgan Sindall 2014 Long Term Incentive Plan (the Plan)

 

Grant of conditional share awards

On 6 March 2017, certain directors of the Company were granted conditional share awards over ordinary shares of 5p each in the capital of the Company ("shares") under the Morgan Sindall 2014 Long Term Incentive Plan ("the Plan").

 

Details of the directors and the number of shares under conditional share awards granted to them under the Plan are set out below:

 

Director

Number of conditional shares awarded

John Morgan

72,636

Steve Crummett

57,918

 

Conditional share awards will normally vest on 6 March 2020 being the third anniversary of the date of grant, subject to continued employment with the Company and satisfaction of the following performance conditions, which are measured over a period of three financial years ending on 31 December 2019:

 

· the number of shares under award representing 100% of the relevant director's salary will be based on a performance condition measuring the Company's earnings per share (EPS). EPS will be expressed in cumulative pence terms and will be equivalent to a growth rate of 6-13% per year over the three-year period; and

 

· the number of shares under award representing 50% of the relevant director's salary will be based on a performance condition measuring the Company's total shareholder return ("TSR") compared with seven of its UK listed peers. TSR will be expressed as an outperformance of median TSR with full vesting for the TSR component requiring 10% per year outperformance of the comparator median.

 

Depending on whether or not the performance conditions are met the directors will receive between 0% and 100% of the award. Details of the performance conditions will be set out in the Directors' Remuneration Report in the Company's 2016 Annual Report (which will be published on or about 27 March 2017).

 

These awards will be subject to a two year holding period on vesting. The base price for calculating the number of conditional shares award was £10.13, the average closing share price between 27 February 2017 and 3 March 2017.

 

No consideration was paid for the grant of the awards.

 

Following the grant of the conditional share awards under the Plan these directors maintain the following beneficial interests in the issued share capital of the Company:

 

Director

Beneficial interest in the shares of the Company

% of the issued share capital of the Company

Total number of shares over which options are held

Total number of conditional share awards held

John Morgan

4,504,352

10.07

106,364

320,630

Steve Crummett

14,615

 0.03

 Nil

248,877

 

This notification relates to transactions notified in accordance with both Disclosure Rule 3.1.4R (1) (a) and Disclosure Rule 3.1.4R (1) (c).

 

 

Contact:

 

Clare Sheridan Tel: 020 7307 9200

Company Secretary

7 March 2017

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHLLFVIVTIDIID
Date   Source Headline
10th May 202311:19 amRNSAdditional Listing
5th May 20232:38 pmRNSHolding(s) in Company
4th May 202312:44 pmRNSResult of AGM
4th May 20237:00 amRNSTrading Update
20th Apr 202310:24 amRNSBlock listing Interim Review
23rd Mar 20231:51 pmRNSAnnual Financial Report
21st Mar 20234:24 pmRNSAdditional Listing
16th Mar 20233:34 pmRNSDirector/PDMR Shareholding
16th Mar 20231:52 pmRNSDirector/PDMR Shareholding
14th Mar 20237:00 amRNSUK Government Self Remediation Contract
13th Mar 20232:40 pmRNSDirector/PDMR Shareholding
3rd Mar 202311:58 amRNSDirector/PDMR Shareholding
3rd Mar 202311:57 amRNSDirector/PDMR Shareholding
2nd Mar 20234:42 pmRNSDirector/PDMR Shareholding
2nd Mar 20234:41 pmRNSDirector/PDMR Shareholding
1st Mar 202311:28 amRNSTotal Voting Rights
23rd Feb 20237:00 amRNSFinal Results
6th Feb 20237:00 amRNSNotice of Full Year Results
1st Feb 20231:04 pmRNSTotal Voting Rights
25th Jan 20232:59 pmRNSHolding(s) in Company
3rd Jan 20231:56 pmRNSTotal Voting Rights
12th Dec 20228:25 amRNSHolding(s) in Company
5th Dec 20223:37 pmRNSHolding(s) in Company
2nd Dec 20229:06 amRNSTotal Voting Rights
7th Nov 20224:08 pmRNSAGM Voting Update
2nd Nov 20227:00 amRNSTrading Update
1st Nov 20221:49 pmRNSTotal Voting Rights
20th Oct 202211:00 amRNSBlock listing Interim Review
18th Oct 20221:16 pmRNSAdditional Listing
3rd Oct 20221:51 pmRNSTotal Voting Rights
13th Sep 20223:27 pmRNSAdditional Listing
1st Sep 202210:43 amRNSTotal Voting Rights
19th Aug 202211:00 amRNSDirector/PDMR Shareholding
4th Aug 20227:00 amRNSHalf-year Report
1st Aug 202210:16 amRNSTotal Voting Rights
11th Jul 20227:00 amRNSNotice of Results
1st Jul 202210:50 amRNSTotal Voting Rights
14th Jun 202212:51 pmRNSAdditional Listing
6th Jun 202212:00 pmRNSTotal Voting Rights
1st Jun 20223:49 pmRNSDirector Declaration
17th May 20221:47 pmRNSHolding(s) in Company
10th May 202211:23 amRNSAdditional Listing
5th May 20224:45 pmRNSResult of AGM
5th May 20227:00 amRNSAGM Trading Update
3rd May 20223:48 pmRNSTotal Voting Rights
20th Apr 202210:25 amRNSBlock listing Interim Review
5th Apr 202210:40 amRNSAdditional Listing
5th Apr 20227:00 amRNSMeet the Management Forum
1st Apr 202210:36 amRNSTotal Voting Rights
24th Mar 202212:46 pmRNSAnnual Financial Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.